CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with early stage breast cancer | Dr Hyman Muss at ASCO 2015

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides an update on the CALGB/CTSU/Alliance 49907 trial... Author: EMJ Added: 08/20/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts